In D-galactose-induced aging mice, oral administration of the product significantly increased NAD+ levels in liver and adipose tissue, activated mitochondrial energy metabolism pathways, improved insulin sensitivity, lowered blood glucose and lipid levels, reduced visceral fat accumulation, and increased energy expenditure, alleviating fatigue and abnormal body weight associated with aging
Environmental science and pollution research international
10.1038/s41586-020-2732-8 Summary Keywords diabetic kidney disease, ferroptosis, kidney biomarkers, pharmacological intervention, SGLT2 inhibitors Citation He S, Wu Z and Li S (2026) Ferroptosis regulation by SGLT2 inhibitors: mechanisms and clinical benefits in diabetic kidney disease
Clinical trials show that people taking Ozempic lost 8 to 10 pounds on average after 30 weeks
"We really need a lot more studies focused on GLP-1 use in this particular patient population, because the majority of what we have is on older adults and diabetes," she says
Structure, function and diversity of the healthy human microbiome